BREAKING NEWS

Teva profits beat forecasts, reports 20% rise in net sales

By HILLEL KOREN/GLOBES

NOVEMBER 2, 2010 11:10

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) reported a 20% rise in third quarter net sales to $4.25 billion, compared with the corresponding period of 2009.

On a non-GAAP basis, net profit was $1.18 billion, or $1.30 in earnings per share (EPS). Net profit rose 47% compared with the corresponding quarter, and EPS rose 46%.

Analysts had expected EPS of $1.27, on revenue of $4.37 billion.

On a GAAP (generally accepted accounting principles) basis, net profit rose 62% compared with the corresponding quarter to $1.1 billion, and EPS of $1.15 was 60% higher than the third quarter of 2009.

Tennessee lawmakers pass bill allowing teachers to carry guns in schools

By REUTERS

04/24/2024 02:11 AM

US VP Harris to Herzog: 'US committed to Israel's security'

By JERUSALEM POST STAFF

04/24/2024 01:58 AM

Launches from Lebanon cross into the area of Margaliot, no alert sounds

By JERUSALEM POST STAFF

04/23/2024 11:26 PM

Two killed by Israeli airstrike in southern Lebanon's Hanin

By REUTERS

04/23/2024 11:20 PM